Skip to main content
. 2014 May 20;4(5):e004885. doi: 10.1136/bmjopen-2014-004885

Table 3.

Overview of randomisation and patient characteristics at baseline (20th April 2014)

Baseline characteristics
Inclusion and randomisation
 Screened 317
 Randomised 177
Characteristics (%)
 Ischaemic heart disease 65
 Diabetes 35
NYHA classes (%)
 1 38
 2 46
 3 16
 0 0
Smoking (%)
 Currently 20
 Previous 52
 Never 28
Treatment (%)
 ACE inhibitor 64
 ARB 30
 Aspirin 63
 β-Blocker 90
 Statin 81
Safety
 Adverse events 224
 Serious adverse events 23

ARB, angiotensin 2 receptor blocker.